SEC Form 4 · accession 0000891293-15-000056

CTI BIOPHARMA CORP · CTIC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — EVP, Finance & Administration

Period of report

Oct 29, 2015

Accepted (ET)

Oct 30, 2015 · 5:49 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000891293

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	Oct 29, 2015	S	1,100	$1.38	D	930,247	D
Common Stock	Oct 29, 2015	S	2,200	$1.39	D	928,047	D
Common Stock	Oct 29, 2015	S	800	$1.40	D	927,247	D
Common Stock	Oct 29, 2015	S	100	$1.4025	D	927,147	D
Common Stock	Oct 29, 2015	S	300	$1.41	D	926,847	D
Common Stock	Oct 29, 2015	S	4,700	$1.42	D	922,147	D
Common Stock	Oct 29, 2015	S	500	$1.4225	D	921,647	D
Common Stock	Oct 29, 2015	S	100	$1.425	D	921,547	D
Common Stock	Oct 29, 2015	S	200	$1.43	D	921,347	D
Common Stock	holding	—	—		—	37	I	Trust for Children

No Table II lines on this filing.